Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study

Laura M. Legue*, Felice N. van Erning, Nienke Bernards, Valery E. P. P. Lemmens, Ignace H. J. T. de Hingh, Geert-Jan Creemers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)699-705
Number of pages7
JournalTargeted Oncology
Volume14
Issue number6
Early online date17 Oct 2019
DOIs
Publication statusPublished - Dec 2019

Keywords

  • PHASE-II
  • COLORECTAL-CANCER
  • PANITUMUMAB PLUS
  • SUPPORTIVE CARE
  • OPEN-LABEL
  • FLUOROURACIL
  • OXALIPLATIN
  • LEUCOVORIN
  • IRINOTECAN
  • CAPECITABINE

Cite this

Legue, Laura M. ; van Erning, Felice N. ; Bernards, Nienke ; Lemmens, Valery E. P. P. ; de Hingh, Ignace H. J. T. ; Creemers, Geert-Jan. / Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma : A Population-Based Study. In: Targeted Oncology. 2019 ; Vol. 14, No. 6. pp. 699-705.
@article{93e751f5ef5f4f01b0047225bdcfcb7b,
title = "Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study",
keywords = "PHASE-II, COLORECTAL-CANCER, PANITUMUMAB PLUS, SUPPORTIVE CARE, OPEN-LABEL, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN, IRINOTECAN, CAPECITABINE",
author = "Legue, {Laura M.} and {van Erning}, {Felice N.} and Nienke Bernards and Lemmens, {Valery E. P. P.} and {de Hingh}, {Ignace H. J. T.} and Geert-Jan Creemers",
year = "2019",
month = "12",
doi = "10.1007/s11523-019-00681-1",
language = "English",
volume = "14",
pages = "699--705",
journal = "Targeted Oncology",
issn = "1776-2596",
publisher = "Springer, Cham",
number = "6",

}

Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma : A Population-Based Study. / Legue, Laura M.; van Erning, Felice N.; Bernards, Nienke; Lemmens, Valery E. P. P.; de Hingh, Ignace H. J. T.; Creemers, Geert-Jan.

In: Targeted Oncology, Vol. 14, No. 6, 12.2019, p. 699-705.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma

T2 - A Population-Based Study

AU - Legue, Laura M.

AU - van Erning, Felice N.

AU - Bernards, Nienke

AU - Lemmens, Valery E. P. P.

AU - de Hingh, Ignace H. J. T.

AU - Creemers, Geert-Jan

PY - 2019/12

Y1 - 2019/12

KW - PHASE-II

KW - COLORECTAL-CANCER

KW - PANITUMUMAB PLUS

KW - SUPPORTIVE CARE

KW - OPEN-LABEL

KW - FLUOROURACIL

KW - OXALIPLATIN

KW - LEUCOVORIN

KW - IRINOTECAN

KW - CAPECITABINE

U2 - 10.1007/s11523-019-00681-1

DO - 10.1007/s11523-019-00681-1

M3 - Article

VL - 14

SP - 699

EP - 705

JO - Targeted Oncology

JF - Targeted Oncology

SN - 1776-2596

IS - 6

ER -